NDC 70436-141

droxidopa

Droxidopa

droxidopa is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Slate Run Pharmaceuticals, Llc. The primary component is Droxidopa.

Product ID70436-141_049f997b-1649-467e-bbb9-bdb991b0bc6e
NDC70436-141
Product TypeHuman Prescription Drug
Proprietary Namedroxidopa
Generic NameDroxidopa
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2021-11-10
Marketing CategoryANDA /
Application NumberANDA215265
Labeler NameSlate Run Pharmaceuticals, LLC
Substance NameDROXIDOPA
Active Ingredient Strength200 mg/1
Pharm ClassesCatecholamines [CS],Increased Blood Pressure [PE]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 70436-141-06

90 CAPSULE in 1 BOTTLE (70436-141-06)
Marketing Start Date2021-11-10
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "droxidopa" or generic name "Droxidopa"

NDCBrand NameGeneric Name
0054-0532DroxidopaDroxidopa
0054-0533DroxidopaDroxidopa
0054-0534DroxidopaDroxidopa
0832-0720DroxidopaDroxidopa
0832-0721DroxidopaDroxidopa
0832-0722DroxidopaDroxidopa
27241-199DroxidopaDroxidopa
27241-200DroxidopaDroxidopa
27241-201DroxidopaDroxidopa
27808-199droxidopadroxidopa
27808-200droxidopadroxidopa
27808-201droxidopadroxidopa
31722-010DroxidopaDroxidopa
31722-014DroxidopaDroxidopa
31722-015DroxidopaDroxidopa
50228-429Droxidopadroxidopa
50228-430Droxidopadroxidopa
50228-431Droxidopadroxidopa
59651-375DroxidopaDroxidopa
59651-376DroxidopaDroxidopa
59651-377DroxidopaDroxidopa
63304-086droxidopadroxidopa
63304-104droxidopadroxidopa
63304-112droxidopadroxidopa
67386-820Northeradroxidopa
67386-821Northeradroxidopa
67386-822Northeradroxidopa

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.